Spero sags after $77M listing

Spero Therapeutics Inc. (NASDAQ:SPRO) sank $2.50 (18%) to $11.50 on Thursday after raising $77 million through the sale of 5.5 million shares

Read the full 223 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE